Page 4 - Arthur Roach News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Echoes is the opinion section of TheBostonPilot.com. The Boston Pilot is a daily news Catholic newspaper based in Boston, Massachusetts, covering news and opinion about the Catholic Church and Catholic life. We carry daily news from Boston, New England, US, the Vatican, Europe, Africa, Asia, and Central and Latin America. The Boston Pilot is part of the Pilot Media Group, America's oldest Catholic newspaper and the official newspaper of the Archdiocese of Boston.

Apr 26 2021 Read 13 Times Researchers at the University of Sheffield have been awarded £1.2 million from Parkinson’s UK to continue with development of a drug that protects dopamine-producing brain cells in efforts to halt the degenerative disease. Dopamine is a chemical which allows messages to be sent to the parts of the brain that help to coordinate movement. To do this effectively, the dopamine-producing brain cells need to be constantly active and they rely on mitochondria to function properly. Scientists from the University’s Institute of Translational Neuroscience (SITraN) led by ...

Parkinson’s UK, University of Sheffield to develop new Parkinson’s drug Parkinson's UK, the largest charitable funder of Parkinson's research in Europe, is investing up to £1.2 million into a pioneering one-year project in partnership with the University of Sheffield. The project aims to refine a molecule that could be developed into a drug to protect dopamine-producing brain cells and slow down the progression of Parkinson's. The funding boost comes via the charity's Parkinson's Virtual Biotech initiative, which is plugging the funding gap in drug development and fast-tracking the devel...

Parkinson’s UK creates Vivifi Biotech to research ‘promising’ experimental treatment 24th February 2021 Charity organisation Parkinson’s UK has announced it is creating a dedicated company to drive forward research into an experimental treatment for Parkinson’s disease. The company, Vivifi Biotech, has been created through the Parkinson’s Virtual Biotech – the drug development arm of Parkinson’s UK. It will seek to further the development of Glial Cell-Line Derived Neurotrophic Factor (GDNF), and investigate if this naturally-occurring protein can regenerate dying brain cells ...